0001203311-14-000053.txt : 20140905
0001203311-14-000053.hdr.sgml : 20140905
20140905191908
ACCESSION NUMBER: 0001203311-14-000053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140904
FILED AS OF DATE: 20140905
DATE AS OF CHANGE: 20140905
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 141086921
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-09-04
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2014-09-04
4
M
0
5600.0
5.92
A
565310
D
Common Stock
2014-09-04
4
S
0
5600.0
42.54
D
559710
D
Common Stock
100000
I
by Trust
Non-Qualified Stock Option (right to buy)
5.92
2014-09-04
4
M
0
5600.0
0.0
D
2015-01-31
Common Stock
5600
16804
D
The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan.
Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Shares vested at a rate of 25% on 1/31/06 and monthly thereafter until all the shares were fully vested on 1/31/09.
Clay B. Siegall
2014-09-05